AMRYT PHARMA LIMITED
Company number 12107859 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-07-17
- Registered office
- C/O Csc Cls (Uk) Limited 5 Churchill Place, 10th Floor, London, United Kingdom, E14 5HU
- Postcode
- E14 5HU
- Capital
- 22 GBP
- Accounts category
- Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-07-16
- Next due by
- 2027-07-30
Nature of business (SIC)
- 70100 Activities of head offices
Officers 4 current · 13 resigned
Michael Russell GORDON
Director
Matthew Hammond WIGGETTS
Director
Matthew Hammond WIGGETTS
Secretary
Andrew Philip DICKINSON
Director
Group structure 1 subsidiary
From persons-with-significant-control filings on the public register.
Contact details
- Website
- amrytpharma.com
We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare diseases.
Previous company names
| Name | Date changed |
|---|---|
| AMRYT PHARMA PLC | 2023-08-04 |
| AMRYT PHARMA HOLDINGS PLC | 2019-09-24 |
| AMRYT PHARMA HOLDINGS LIMITED | 2019-09-13 |
The class of 2019
51%
of the 1,430 companies in this sector incorporated in 2019 are still active today; 43% have since been dissolved.
A fact about the year, not a forecast for this company.